Medical Pharmaceutical Supply – Sodium Chloride Injection

The contract obligates the supplier to manufacture and deliver sterile Sodium Chloride Injection identified by NSN 6505013306269, ensuring strict adherence to FDA and USP standards for pharmaceutical purity and safety. The product is intended for medical use aboard U.S. Navy vessels and requires end-to-end traceability throughout production, packaging, and shipment to support military readiness and patient safety. All processes must comply with Defense Logistics Agency logistics protocols and inspection requirements, including documentation for quality control, lot tracking, and regulatory compliance. This is a subcontract under the Department of Defense, managed by the Defense Logistics Agency, with a NAICS code of 325412 designating it within the pharmaceutical and medicine manufacturing sector. The contract was posted on June 26, 2026, and is linked to the award SPE2DX25D8022 with delivery order SPE2D926F6897. The place of performance and specific point of contact are not listed, but full compliance with DLA’s supply chain and quality assurance systems is mandatory, ensuring the product meets the rigorous demands of federal military healthcare operations.